34
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Tolerance of Efavirenz-Induced Central Nervous System Side Effects in HIV-Infected Individuals with a History of Substance Abuse

, &
Pages 145-149 | Published online: 02 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Esileman Abdela Muche, Mekdes Kiflu & Mohammed Biset Ayalew. (2020) Patient Reported Central Nervous System Adverse Events of Efavirenz-Based Antiretroviral Therapy in People Living with HIV in Northwest Ethiopia. HIV/AIDS - Research and Palliative Care 12, pages 601-609.
Read now
Gabriele Arendt, Dominique de Nocker, Hans-Juergen von Giesen & Thorsten Nolting. (2007) Neuropsychiatric side effects of efavirenz therapy. Expert Opinion on Drug Safety 6:2, pages 147-154.
Read now
Trevor Hawkins, Cindy Geist, Ben Young, A. Giblin, Renee C. Mercier, Karla Thornton & Richard Haubrich. (2005) Comparison of Neuropsychiatric Side Effects in an Observational Cohort of Efavirenz- and Protease Inhibitor-Treated Patients. HIV Clinical Trials 6:4, pages 187-196.
Read now
Trevor Hawkins, Cindy Geist, Ben Young, A. Giblin, Renee C. Mercier, Karla Thornton & Richard Haubrich. (2005) Comparison of Neuropsychiatric Side Effects in an Observational Cohort of Efavirenz- and Protease Inhibitor-Treated Patients. HIV Clinical Trials 6:4, pages 187-196.
Read now

Articles from other publishers (8)

Nicholas Zareifopoulos, Maria Lagadinou, Anastasia Karela, Ourania Kyriakopoulou & Dimitrios Velissaris. (2020) Neuropsychiatric Effects of Antiviral Drugs. Cureus.
Crossref
Angela M Bengtson, Brian W Pence, Ellen F Eaton, Jessie K Edwards, Joseph J Eron, William C Mathews, Katie Mollan, Richard D Moore, Connall O'Cleirigh, Elvin Geng & Michael J Mugavero. (2017) Patterns of Efavirenz use as First-Line Antiretroviral Therapy in the United States: 1999–2015. Antiviral Therapy 23:4, pages 363-372.
Crossref
Nadezda Apostolova, Haryes A. Funes, Ana Blas-Garcia, Maria J. Galindo, Angeles Alvarez & Juan V. Esplugues. (2015) Efavirenz and the CNS: what we already know and questions that need to be answered. Journal of Antimicrobial Chemotherapy 70:10, pages 2693-2708.
Crossref
Christopher A. Kenedi & Harold W. Goforth. (2011) A Systematic Review of the Psychiatric Side-Effects of Efavirenz. AIDS and Behavior 15:8, pages 1803-1818.
Crossref
Jennifer King & Judith A Aberg. (2008) Clinical impact of patient population differences and genomic variation in efavirenz therapy. AIDS 22:14, pages 1709-1717.
Crossref
Michelle S Cespedes & Judith A Aberg. (2006) Neuropsychiatric Complications of Antiretroviral Therapy. Drug Safety 29:10, pages 865-874.
Crossref
Christian Dolder & Beatriz Luna. 2006. Psychiatry for Neurologists. Psychiatry for Neurologists 313 328 .
. (2004) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 13:3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.